Cantel Medical has divested Saf-T-Pak, its specialty packaging business, effective April 7.
"The sale of our Saf-T-Pak business enables Cantel Medical to better focus on our core markets and strategic opportunities. Specialty packaging no longer fits our strategic growth objectives," said Andrew Krakauer, CEO of Cantel Medical.
The net proceeds from the sale, after taxes, are expected to be $7 million.